159 related articles for article (PubMed ID: 12325100)
1. Monitoring clinical trials: issues and controversies regarding confidentiality.
Fleming TR; Ellenberg S; DeMets DL
Stat Med; 2002 Oct; 21(19):2843-51. PubMed ID: 12325100
[TBL] [Abstract][Full Text] [Related]
2. Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al.
Korn EL; Hunsberger S; Freidlin B; Smith MA; Abrams JS
Clin Trials; 2008; 5(4):364-5; author reply 365-6. PubMed ID: 18697851
[No Abstract] [Full Text] [Related]
3. Role of the Data and Safety Monitoring Committee (DSMC).
Wilhelmsen L
Stat Med; 2002 Oct; 21(19):2823-9. PubMed ID: 12325098
[TBL] [Abstract][Full Text] [Related]
4. What is the appropriate role of the trial statistician in preparing and presenting interim findings to an independent Data Monitoring Committee in the U.S. Cancer Cooperative Group setting?
Bryant J
Stat Med; 2004 May; 23(10):1507-11. PubMed ID: 15122728
[TBL] [Abstract][Full Text] [Related]
5. The independent statistician for data monitoring committees.
DeMets DL; Fleming TR
Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
Tijssen JG
Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062
[TBL] [Abstract][Full Text] [Related]
7. [Interim analyses].
Kramar A; Paoletti X
Bull Cancer; 2007 Nov; 94(11):965-74. PubMed ID: 18055314
[TBL] [Abstract][Full Text] [Related]
8. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
[TBL] [Abstract][Full Text] [Related]
9. Futility approaches to interim monitoring by data monitoring committees.
Demets DL
Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036
[TBL] [Abstract][Full Text] [Related]
10. Interim futility analysis with intermediate endpoints.
Goldman B; LeBlanc M; Crowley J
Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
[TBL] [Abstract][Full Text] [Related]
11. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
12. The other side of clinical trial monitoring; assuring data quality and procedural adherence.
Williams GW
Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037
[TBL] [Abstract][Full Text] [Related]
13. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
Ellenberg SS; George SL
Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
[TBL] [Abstract][Full Text] [Related]
14. Strength of accumulating evidence and data monitoring committee decision making.
George SL; Freidlin B; Korn EL
Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
[TBL] [Abstract][Full Text] [Related]
15. Data Monitoring Committees: Current issues.
Fleming TR; Ellenberg SS; DeMets DL
Clin Trials; 2018 Aug; 15(4):321-328. PubMed ID: 29629815
[TBL] [Abstract][Full Text] [Related]
16. Current controversies in data monitoring for clinical trials.
Pocock SJ
Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
[TBL] [Abstract][Full Text] [Related]
17. Regulatory perspectives on data monitoring.
O'Neill RT
Stat Med; 2002 Oct; 21(19):2831-42. PubMed ID: 12325099
[TBL] [Abstract][Full Text] [Related]
18. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
[TBL] [Abstract][Full Text] [Related]
19. Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data.
Heller G; Kattan MW; Scher HI
Med Decis Making; 2007; 27(4):380-6. PubMed ID: 17761958
[TBL] [Abstract][Full Text] [Related]
20. Role of the data safety and monitoring board in an international trial.
NIMH Collaborative HIV/STD Prevention Trial
AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
